Transvalvular Intraanular Band and Chordae Cutting for Mitral Valve Treatment

The USPTO granted Patent US12588995B2 to Heart Repair Technologies, Inc., covering a transvalvular intraannular band for treating mitral valve prolapse and mitral regurgitation in ischemic and dilated cardiomyopathy patients. The patent (Application No. 17356955, 20 claims, inventors: Valavanur A. Subramanian, Thomas Afzal, Gary Hulme, Jeffrey Christian, Michael L. Reo) describes positioning a band transversely across the coaptive edge formed by mitral valve leaflet closure to inhibit prolapse into the left atrium, with at least one marginal chordae severed to permit leaflet closure against the band.

This patent grant establishes intellectual property rights for Heart Repair Technologies in the US market for this specific cardiac implant technology. Medical device companies developing competing transcatheter mitral valve repair devices should review this patent for potential licensing needs or design-around considerations. The patent does not impose compliance obligations but defines protected technology boundaries in the cardiac device space.